What Is Driving Global Restless Leg Syndrome Market Growth in 2025: The Role of Iron Deficiency Drives The Growth Of The Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Restless Leg Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market encompassing restless leg syndrome has experienced swift expansion over the past few years, projected to climb from a valuation of $1.91 billion in 2024 to $2.16 billion in 2025, reflecting a compound annual growth rate of 13.5%. Factors contributing to this expansion during the historical timeframe include the rising prevalence of alcohol consumption, broader access to health insurance, greater accessibility of non-prescription pharmaceuticals, escalating public health campaigns, and a noticeable increase in mental health concerns.

How Will the Restless Leg Syndrome Market Size Evolve and Grow by 2029?
Anticipation suggests the restless leg syndrome market will expand quickly across the upcoming years, reaching a value of $3.55 billion by 2029, propelled by a compound annual growth rate (CAGR) of 13.2%; this upswing across the projected timeframe is attributable to greater financial outlays in healthcare, heightened educational and awareness initiatives, advancements in timely diagnosis, augmented governmental support, and greater engagement in clinical research endeavors.

View the full report here:
https://www.thebusinessresearchcompany.com/report/restless-leg-syndrome-global-market-report

What Drivers Are Propelling the Growth of Restless Leg Syndrome Market Forward?
The rising incidence of iron deficiency is anticipated to serve as a key catalyst for the expansion of the restless leg syndrome market moving ahead. This condition, characterized by the body's insufficient iron levels for adequate healthy red blood cell formation, manifests through symptoms including weakness, tiredness, and pallor, stemming from causes like inadequate nutrition, hemorrhaging, issues with nutrient absorption, and heightened iron needs during stages such as gestation or development. Therapeutic approaches for restless leg syndrome frequently incorporate iron supplements or dietary modifications; these interventions serve the dual purpose of easing the disruptive sensations while concurrently addressing the root iron deficit by restoring bodily iron reserves, thereby enhancing the creation of red blood cells and normalizing neurological processes. To illustrate this trend, data published in January 2025 by the Nation Health Service England, a governing body in England, indicated that admissions attributed to iron deficiency reached 191,927 across the 2023-24 timeframe, marking an 11% year-over-year escalation from 2022-23 figures, underscoring how the growing frequency of iron deficiency is fueling the market for restless leg syndrome treatment.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21274&type=smp

Which Emerging Trends Are Transforming the Restless Leg Syndrome Market in 2025?
Within the dynamic restless leg syndrome (RLS) market, leading firms are heavily investing in creating breakthrough treatments, particularly novel non-invasive therapeutic approaches, with the goal of refining symptom control and boosting patient recovery rates. These innovative non-surgical treatments involve employing advanced methodologies like light therapy, electrical stimulation, or external mechanisms, designed to offer relief without the need for surgical intrusion or skin piercing. Illustratively, in April 2023, the FDA granted De Novo clearance to the NTX100 Tonic Motor Activation (TOMAC) System, developed by Varco Leg Care, an Indian firm specializing in consumer health-technology. This apparatus, the NTX100 TOMAC System, has been engineered for managing moderate to severe RLS manifestations and elevating sleep quality for individuals unresponsive to pharmaceutical interventions. Operationally, the system functions by delivering electrical activation to the peroneal nerves bilaterally, thereby inducing a sustained, tonic muscle engagement that is conducive to sleep, which effectively mitigates the characteristic signs of restless leg syndrome.

What Are the Key Segments in the Restless Leg Syndrome Market?
The restless leg syndromemarket covered in this report is segmented -

1) By Type: Primary Restless Legs Syndrome; Secondary Restless Legs Syndrome
2) By Treatment Type: Medicine And Devices; Surgery
3) By Route Of Administration: Oral; Injectable
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
5) By Application: Neurological Treatment; Sleep Disorders; Movement Disorders; Symptom Management

Subsegments:
1) By Primary Restless Legs Syndrome: Idiopathic Restless Legs Syndrome; Hereditary Restless Legs Syndrome
2) By Secondary Restless Legs Syndrome: Iron Deficiency-related Restless Legs Syndrome; Chronic Kidney Disease-related Restless Legs Syndrome; Pregnancy-related Restless Legs Syndrome; Medication-induced Restless Legs Syndrome

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21274&type=smp

Who Are the Key Players Shaping the Restless Leg Syndrome Market's Competitive Landscape?
Major companies operating in the restless leg syndrome market are Pfizer Inc., Roche Holding AG, Merck & Co Inc., Novartis International AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Baxter International Inc., Astellas Pharma Inc., UCB S.A., Kyowa Kirin Co Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Mundipharma International Limited, Azurity Pharmaceuticals LLC, Otsuka Pharmaceutical Co Ltd., Horizon Therapeutics plc, Mylan N.V., Apollo Pharmacy Limited

What Geographic Markets Are Powering Growth in the Restless Leg Syndrome Market?
Europe was the largest region in the restless leg syndrome market in 2024. North-America is expected to be the fastest-growing region in the forecast period. The regions covered in the restless leg syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21274

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.